UBS OCONNOR LLC - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 88 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2014$204,000,000
-85.6%
50,000
-84.3%
0.00%
-85.2%
Q2 2013$1,419,000,000–318,191–0.03%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q1 2014.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders